Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Amortizatization of Intangibles (2021 - 2025)

Kezar Life Sciences' Amortizatization of Intangibles history spans 5 years, with the latest figure at $494000.0 for Q3 2025.

  • For Q3 2025, Amortizatization of Intangibles fell 59.71% year-over-year to $494000.0; the TTM value through Sep 2025 reached $2.7 million, down 52.58%, while the annual FY2024 figure was $5.0 million, 26.16% down from the prior year.
  • Amortizatization of Intangibles for Q3 2025 was $494000.0 at Kezar Life Sciences, down from $587000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $1.8 million in Q2 2023 and bottomed at -$531000.0 in Q2 2021.
  • The 5-year median for Amortizatization of Intangibles is $688000.0 (2025), against an average of $698578.9.
  • The largest annual shift saw Amortizatization of Intangibles soared 857.92% in 2023 before it crashed 59.71% in 2025.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$317000.0 in 2021, then surged by 527.76% to $1.4 million in 2022, then increased by 12.98% to $1.5 million in 2023, then plummeted by 40.27% to $915000.0 in 2024, then tumbled by 46.01% to $494000.0 in 2025.
  • Per Business Quant, the three most recent readings for KZR's Amortizatization of Intangibles are $494000.0 (Q3 2025), $587000.0 (Q2 2025), and $688000.0 (Q1 2025).